Psoriasis Trial, Recruiting NCT07536529 Sponsor: University of Thessaly Condition: Psoriasis
Back to Psoriasis

Psoriasis Trial, Recruiting

NCT07536529
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • You have been diagnosed with rheumatoid arthritis (a condition where the immune system attacks the joints, causing pain and swelling)
  • You have been diagnosed with psoriatic arthritis (a type of joint inflammation linked to the skin condition psoriasis)
  • You have been diagnosed with ankylosing spondylarthritis (a type of arthritis that mainly affects the spine)
  • You can be of any gender
  • You can be of any ethnic background
  • You can have other health conditions alongside your arthritis
  • You can be from any socioeconomic background
  • Your arthritis can be at any stage or level of severity
  • You can have had your diagnosis for any length of time
  • You can be on any current treatment, including anti-inflammatory medicines, steroids, or specialist drugs such as biologics

Who may not be able to join:

  • You currently have an active infection or infectious disease
  • You are currently pregnant
  • You are under 18 years of age

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Thessaly
Registry
ClinicalTrials.gov
Start date
6 October 2025
Est. completion
30 April 2026

Where this trial is recruiting

🇬🇷 Greece

Primary endpoints

Concentration of blood reduced glutathione (GSH)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov